News
$SGMO.US$ Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement With Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases! Eligeable to receive upto 1.9 billion in milestone payments
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
